Services to COVID-19 vaccine developers

From Transvac initiative

TRANSVAC is dedicated to accelerate vaccine candidates across the R&D pipeline, by offering services to vaccine developers in academic and industry settings.

TRANSVAC services cover all aspects of vaccine development, for any target disease, for prophylactic, therapeutic, human and veterinary vaccines:

🧬Cross-platform screening and optimisation
🔬 Analytical Services
🧪 Adjuvants and delivery systems
⚗ Pre-clinical GLP Production Services
💉 GMP Production Services (Paid)
⚛ Structural Biology
📊 Immunocorrelates and Systems Biology
🐑 Animal Models
🩺 Clinical Trial support

 

COVID-19 vaccine development

 

Researchers developing vaccine candidates against COVID19 can also benefit from TRANSVAC2 services, namely but not exclusively:

Animal models

• CEA
• BPRC
• IRTA
• CReSA Centre de Recerca en Sanitat Animal and Helmholtz Centre for Infection Research (HZI)

Adjuvant formulation

• VACCINE FORMULATION INSTITUTE LIMITED
• HZI

Clinical Trial Support

• ECRIN (European Clinical Research Infrastructure Network)

Regulatory support

• EATRIS and European Vaccine Initiative

You can visit www.transvac.org for more information.